Healthcare Services

Leukocytosis Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

April 2, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Leukocytosis Market Between 2026 And 2030?

The leukocytosis market has seen significant expansion in recent years. It is forecast to rise from $5.13 billion in 2025 to $5.41 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.4%. The historical progress of this market can be linked to the widespread occurrence of infectious diseases, an increasing number of inflammatory disorders, a rise in leukemia cases, the continued reliance on conventional blood tests, and the expansion of hospital-based diagnostic services.

The leukocytosis market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $6.63 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.2%. Key factors contributing to this growth during the forecast period include advancements in hematology diagnostics, the increasing adoption of personalized treatment methods, greater awareness regarding early disease detection, a rise in healthcare spending, and the expansion of laboratory automation. Prominent trends identified for the forecast period encompass the expanding adoption of sophisticated blood diagnostics, an increasing emphasis on disease-specific treatments, the growing application of precision medicine within hematology, the proliferation of automated and high-throughput testing, and the increasing integration of clinical decision support systems.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24278&type=smp

What Major Drivers Are Influencing Demand In The Leukocytosis Market?

The leukocytosis market is anticipated to expand due to the growing prevalence of blood-related illnesses. These conditions involve disorders impacting components of blood like red and white blood cells, platelets, or plasma. The increase in these diseases is linked to aging demographics, as older individuals are more vulnerable to issues such as anemia, leukemia, and clotting disorders, often due to weakened immune systems and accumulated health problems. Often, blood-related diseases lead to elevated white blood cell counts, a hallmark of leukocytosis, which underscores the necessity for improved early detection, better monitoring instruments, and more efficacious therapeutic approaches. For example, the American Cancer Society, a US-based cancer organization, reported 62,770 new cases of leukemia in 2024, a notable rise from 59,610 cases in 2023. Consequently, the rising occurrence of blood-related conditions is propelling the expansion of the leukocytosis market.

Which Market Segments Are Examined In The Leukocytosis Market Study?

The leukocytosis market covered in this report is segmented –

1) By Disease Type: Infection, Leukemia

2) By Diagnosis Type: Blood Tests, Bone Marrow Biopsy

3) By End User: Hospitals, Diagnostic Laboratories

Subsegments:

1) By Infection: Bacterial Infections, Viral Infections, Parasitic Infections, Fungal Infections

2) By Leukemia: Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia (ALL) with Hyperleukocytosis

Which Upcoming Trends Are Expected To Influence The Leukocytosis Market?

Leading firms in the leukocytosis market are prioritizing the incorporation of artificial intelligence into diagnostic systems to improve early disease identification, diagnostic precision, and tailored treatment strategies. This involves employing AI technologies like machine learning, deep learning, and natural language processing to analyze medical data, thereby assisting or automating disease diagnosis. As an illustration, in December 2024, Koninklijke Philips NV, a healthcare company based in the Netherlands, introduced its CT 5300 system. This system incorporates proprietary artificial intelligence technologies designed to optimize computed tomography (CT) imaging processes. The CT 5300 system includes a computed tomography smart workflow, which utilizes AI-powered tools such as precise position, precise cardiac, and precise brain, effectively streamlining scan preparation, boosting diagnostic accuracy, and minimizing radiation exposure.

Who Are The Primary Competitors In The Leukocytosis Market?

Major companies operating in the leukocytosis market are Pfizer Inc., Johnson & Johnson, Siemens Healthineers AG, Roche Diagnostics AG, Bristol Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis International AG, Danaher Corporation, Merck KGaA, Becton Dickinson and Company (BD), Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics, Agilent Technologies Inc., Grifols SA, Hologic Inc., Illumina Inc., PerkinElmer Inc., Sysmex Corporation, Beckman Coulter Diagnostics Inc., Bio-Rad Laboratories, Bio-Techne Corporation, NeoGenomics Laboratories Inc., DiaSorin S.p.A.

Read the full leukocytosis market report here:

https://www.thebusinessresearchcompany.com/report/leukocytosis-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Leukocytosis Market?

North America was the largest region in the leukocytosis market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the leukocytosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Leukocytosis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24278&type=smp

Browse Through More Reports Similar to the Global Leukocytosis Market 2026, By The Business Research Company

Progressive Multifocal Leukoencephalopathy Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/progressive-multifocal-leukoencephalopathy-treatment-global-market-report

Pheochromocytoma Global Market Report

https://www.thebusinessresearchcompany.com/report/pheochromocytoma-global-market-report

Leukotriene Modifiers Global Market Report

https://www.thebusinessresearchcompany.com/report/leukotriene-modifiers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795